Insiders Updates An Analysis of Arbutus Biopharma Corp (ABUS)’s Potential Price Growth In a filing, Arbutus Biopharma Corp revealed its Director McElhaugh Michael J. acquired Company’s shares for reported $0.8 million on
Stock Earnings Arbutus Biopharma Corp [ABUS] short interest surges, jumping by 12.75 million million shares Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Arbutus Biopharma